Molecular mechanisms of anticancer activity of n-glycosides of indolocarbazoles lcs-1208 and lcs-1269

Novel indolocarbazole derivatives named LCS were synthesized by our research group. Two of them were selected as the most active anticancer agents in vivo. We studied the mechanisms of anticancer activity in accordance with the previously described effects of indolocarbazoles. Cytotoxicity was estimated by MTT assay. We analyzed LCS-DNA interactions by circular dichroism in cholesteric liquid crystals and fluorescent indicator displacement assay. The effect on the activity of topoisomerases I and II was studied by DNA relaxation assay. Expression of interferon signaling target genes was estimated by RT-PCR. Chromatin remodeling was analyzed–the effect on histone H1 localization and reactivation of epigenetically silenced genes. LCS-induced change in the expression of a wide gene set was counted by means of PCR array. Our study revealed the cytotoxic activity of the compounds against 11 cancer cell lines and it was higher than in immortalized cells. Both compounds bind DNA; binding constants were estimated—LCS-1208 demonstrated higher affinity than LCS-1269; it was shown that LCS-1208 intercalates into DNA that is typical for rebeccamycin derivatives. LCS-1208 also inhibits topoisomerases I and IIα. Being a strong intercalator and topoisomerase inhibitor, LCS-1208 upregulates the expression of interferon-induced genes. In view of LCSs binding to DNA we analyzed their influence on chromatin stability and revealed that LCS-1269 displaces histone H1. Our analysis of chromatin remodeling also included a wide set of epigenetic experiments in which LCS-1269 demonstrated complex epigenetic activity. Finally, we revealed that the antitumor effect of the compounds is based not only on binding to DNA and chromatin remodeling but also on alternative mechanisms. Both compounds induce expression changes in genes involved in neoplastic transformation and target genes of the signaling pathways in cancer cells. Despite of being structurally similar, each compound has unique biological activities. The effects of LCS-1208 are associated with intercalation. The mechanisms of LCS-1269 include influence on higher levels such as chromatin remodeling and epigenetic effects. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Authors
Zenkov R.G.1 , Vlasova O.A.1 , Maksimova V.P.1 , Fetisov T.I.1 , Karpechenko N.Y.1 , Ektova L.V.1 , Eremina V.A.1 , Popova V.G.1, 2 , Usalka O.G.1, 3 , Lesovaya E.A.1, 4 , Belitsky G.A. 1 , Yakubovskaya M.G. 1 , Kirsanov K.I. 1, 5
Journal
Publisher
MDPI AG
Number of issue
23
Language
English
Status
Published
Number
7329
Volume
26
Year
2021
Organizations
  • 1 N. N. Blokhin Russian Cancer Research Center, 24 Kashirskoe Shosse, Moscow, 115478, Russian Federation
  • 2 Faculty of Biotechnology and Industrial Ecology, Mendeleev University of Chemical Technology of Russia, 9 Miusskaya Ploshchad, Moscow, 125047, Russian Federation
  • 3 International School “Medicine of the Future”, I.M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, 119991, Russian Federation
  • 4 Department of Oncology, I.P. Pavlov Ryazan State Medical University, 9 Vysokovoltnaya St., Ryazan, 390026, Russian Federation
  • 5 Institute of Medicine, RUDN University, 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
Keywords
Antitumor activity; Chromatin remodeling; Epigenetics; Indolocarbazoles; Intercalation; Interferon; LCS-1208; LCS-1269
Date of creation
16.12.2021
Date of change
16.12.2021
Short link
https://repository.rudn.ru/en/records/article/record/76437/
Share

Other records